?Dear doctor???Evaluating the impact of risk communication efforts

Pharmacoepidemiology and Drug SafetyVolume 12, Issue 4 p. 291-293 Editorial ‘Dear doctor…’—Evaluating the impact of risk communication efforts† Paul J. Seligman MD, MPH, Corresponding Author Paul J. Seligman MD, MPH [email protected] Office of Pharmacoepidemiology and Statistical Science, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, USADirector, Office of Pharmacoepidemiology and Statistical Science, Center...